#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dementia with Lewy bodies Retinopathy of prematurity Rhabdoid tumour Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Conjunctivitis allergic Familial dilated cardiomyopathy Squamous cell carcinoma of the cervix Myocarditis T-cell lymphoma Congenital pseudarthrosis Crohn's disease Demyelination B-cell lymphoma refractory Anaplastic large cell lymphoma T- and null-cell types Neuroblastoma recurrent More trials…

    Learn about Rare Diseases

    Primary biliary cholangitis – Trials in Disease Encephalitis autoimmune – Basic Information Pemphigus – Treatment Mantle cell lymphoma stage II – Life with Disease Medulloblastoma Nodal marginal zone B-cell lymphoma – Trials in Disease Choroid melanoma Phenylketonuria Shprintzen-Goldberg syndrome – Treatment Cystic fibrosis lung – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lorazepam Diazepam Specific Nucleic Acid Sna-Her1 Trehalose Dihydrate (Ph.eur.) Ro7269162 Treosulfan ARI0008 Patritumab Deruxtecan Amylase Tak-280 Cefalexin Monohydrate Cctx-001 Hyoscine Butylbromide Masofaniten Rgx-202 F125/10 Tiratricol Ttf-Ngr Ofloxacin Salmeterol More therapies…

    Learn about Your Condition

    Optic atrophy Congenital aplastic anaemia Endocarditis Hairy cell leukaemia Dementia with Lewy bodies Fracture infection Gastric cancer Mixed dementia Anal cancer metastatic Ovarian cancer stage IV Ovarian cancer Poor quality sleep Pancreatitis acute Microvillous inclusion disease Colitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Systemic lupus erythematosus

  • Comparing certolizumab pegol and belimumab for patients with moderate or severe systemic lupus erythematosus

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Certolizumab Pegol
    • Belimumab
    Poland

  • Study of B Cell Response to Tetanus Toxoid Vaccination in Patients with Systemic Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Systemic scleroderma
    • Systemic lupus erythematosus
    Investigated Drugs:
    • TETANUS TOXOID
    The Netherlands

  • Study of Telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Telitacicept
    Bulgaria Czechia France Germany Hungary Poland +1

  • Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lupus nephritis
    • Systemic lupus erythematosus
    Investigated Drugs:
    • CC-97540
    • Fludarabine
    • Fludarabine Phosphate
    Austria Belgium Denmark France Germany Italy +3

  • Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Giant cell arteritis
    • Polymyalgia rheumatica
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Sweden

  • Study on the Effectiveness of Telitacicept for Adults with Moderate to Severe Systemic Lupus Erythematosus

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Telitacicept
    Croatia France Greece Italy Poland Romania
Previous Page
1 … 3 4 5 6 7 … 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!